Who was Barbara Mitchell?
  1. Author Library
  2. Author Library

Author Library

Who Bears the Burden of Property Taxes in Canada’s Largest Metropolitan Areas?
By Josef Filipowicz, Steven Globerman | October 17, 2019
The Costs of Slow Economic Growth: Collected Essays
By Steven Globerman | October 10, 2019
Private health insurance, not government bureaucracy, spurs health-care innovation
By Steven Globerman | September 13, 2019
Health care cannot modernize unless health policy changes first
By Bacchus Barua, Steven Globerman | August 20, 2019
Canada can’t escape Trump administration’s war on trade
By Steven Globerman | August 6, 2019
Federal government should give greater weight to education credentials to attract ‘elite’ immigrants
By Steven Globerman | July 26, 2019
Highly Educated Immigrants: Economic Contributions and Implications for Public Policy
By Steven Globerman | July 23, 2019
Artificial Intelligence will kill jobs—and create them
By Steven Globerman | July 12, 2019
Dramatic drop in capital expenditures threatens Canada’s economic prosperity
By Steven Globerman | July 12, 2019
Technology, Automation, and Employment: Will this Time be Different?
By Steven Globerman | July 9, 2019
Private Sector Capital Expenditures in Canada: An Industry-Level Analysis
By Steven Globerman, Joel Emes | July 3, 2019
Trump’s tariff tactics will end badly for U.S.—and Canada
By Steven Globerman | June 4, 2019
Foreign investment in Canada—nothing to celebrate
By Steven Globerman | May 24, 2019
Canada’s upstream oil and gas sector—from the outpatient clinic to intensive care
By Steven Globerman, Joel Emes | May 16, 2019
Slowdown of world economic growth would likely reduce demand for Canadian resource exports
By Steven Globerman | May 14, 2019
Investment in the Canadian and U.S. Oil and Gas Sectors: A Tale of Diverging Fortunes
By Steven Globerman, Joel Emes | May 7, 2019
Americans want prescription drugs from Canada
By Steven Globerman | April 18, 2019
Paying companies to stay—bad idea
By Steven Globerman | March 27, 2019
Canadian Foreign Direct Investment: Recent Patterns and Interpretation
By Steven Globerman | March 21, 2019
Private sector helping address physician scarcity in the U.S.
By Steven Globerman, Bacchus Barua | March 13, 2019
Trudeau government's drug-pricing plan may limit access to new life-improving medicines
By Bacchus Barua, Steven Globerman | February 21, 2019
'Tax the rich' movement in the U.S. may benefit Canada
By Steven Globerman | February 11, 2019
Pharmaceutical Regulation, Innovation, and Access to New Drugs: An International Perspective
By Steven Globerman, Bacchus Barua | January 24, 2019
Canadian policymakers should learn from Trump's supply-side success
By Steven Globerman | January 17, 2019
Despite decades of government subsidies, Canadian innovation has waned
By Steven Globerman | January 15, 2019
Innovation in Canada: An Assessment of Recent Experience
By Steven Globerman, Joel Emes | January 15, 2019
Canada's free ride on U.S. drug development may end soon
By Steven Globerman, Bacchus Barua | December 11, 2018
Regulatory reform in Canada should focus on streamlining deregulation
By Steven Globerman | November 27, 2018
NAFTA renegotiations—a missed opportunity for Canada
By Steven Globerman, Gary Hufbauer | November 19, 2018
The Flight of Capital From Canada
By Niels Veldhuis, Jason Clemens, Milagros Palacios, Steven Globerman | November 19, 2018
U.S. market won't save Canada's oil sector
By Steven Globerman | November 16, 2018
A split Congress may increase uncertainty surrounding Canada’s trade environment
By Steven Globerman | November 8, 2018
The United States–Mexico–Canada Agreement: Overview and Outlook
By Gary Hufbauer, Steven Globerman | November 1, 2018
Wake up—Canada has a business investment crisis
By Steven Globerman | October 24, 2018
Strategies for Deregulation: Concepts and Evidence
By Steven Globerman | October 23, 2018
Capital Investment in Canada: An International Comparison
By Steven Globerman, Trevor Press | October 11, 2018
New trade pact mixed bag for Canadians
By Steven Globerman | October 3, 2018
Trudeau government should concede on key NAFTA issues for the benefit of most Canadians
By Steven Globerman, Gary Hufbauer | October 1, 2018
The Canadian economy at the precipice
By Steven Globerman | September 18, 2018
Capital Investment in Canada: Recent Behaviour and Implications
By Steven Globerman, Trevor Press | September 13, 2018
Foreign investors say Canada has a competitiveness problem
By Steven Globerman | September 7, 2018
Canada's trade hurdle—it's all about supply management
By Steven Globerman | September 4, 2018
Timely health care—there’s an app for that!
By Bacchus Barua, Steven Globerman | August 31, 2018
Canada should not follow the U.S. down a path to corporate socialism
By Steven Globerman | August 23, 2018
Protectionism on the rise as NAFTA talks stall
By Steven Globerman | July 25, 2018
Trump administration summons ‘national security’ to justify tariffs
By Steven Globerman | July 18, 2018
In the evolving trade debacle with the U.S, Ottawa must act
By Steven Globerman | July 3, 2018
Stemming the demographic tide on U.S. entrepreneurship
By Steven Globerman, Jason Clemens | June 25, 2018
Through the WTO, Canada could reaffirm its commitment to multilateral institutions
By Steven Globerman | June 15, 2018
Demographics and Entrepreneurship blog series: The role of immigration in entrepreneurship
By Steven Globerman | June 6, 2018